FIELD: chemistry.
SUBSTANCE: present invention refers to the compound 5-[3-[(2S)-1-(difluoromethoxy)-propane-2-yl]-oxy-5-[(5-methylpyrazin-2-yl)-carbamoyl]]phenoxy]-N,N-dimethyl-pyrazine-2-carboxamide. The invention also refers to a pharmaceutical composition, and also to application of the compound under cl.1.
EFFECT: making the new biologically active compounds showing GLK (glucokinase) activator activity.
5 cl, 6 ex, 2 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2809631C2 |
| IMIDAZOPIRASOTHINES AS PDE1 INHIBITORS | 2016 |
|
RU2712219C2 |
| COMPOSITIONS CONTAINING BENZOPIPERAZINE AS BROMODOMAIN BET INHIBITORS | 2014 |
|
RU2720237C2 |
| BICYCLIC CONDENSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS | 2016 |
|
RU2684324C1 |
| SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
| HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS | 2017 |
|
RU2742115C2 |
| PYRAZOLE PYRIMIDINE DERIVATIVES AND USING THEM AS PDE10 INHIBITORS | 2011 |
|
RU2543386C2 |
| PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
| DIHYDROPTHERIDINONE DERIVATIVES, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2010 |
|
RU2559881C2 |
Authors
Dates
2012-01-27—Published
2007-10-25—Filed